Dr. Sanjay Gupta is a Professor & Research Director and holds Carter Kissell Endowed Chair in Urologic Oncology in the Department of Urology at Case Western Reserve University and The Urology Institute at the University Hospitals Case Medical Center. He also holds secondary appointments in the Departments of Nutrition and Division of General Medical Sciences at Case Comprehensive Cancer Center. Dr. Gupta obtained faculty position in 2002 at Case Western Reserve University, School of Medicine. Dr. Gupta’s research involves basic, translational and clinical areas of focus. In basic research his focus is to understand the risk factors and mechanisms of prostatic and bladder diseases and develop appropriate biomarkers for early detection and prognosis. Translational research focus is to identify novel targets to monitor the efficacy of various synthetic and natural agents and develop them as chemo preventatives/therapeutics. His clinical research interests are translation of bench research to its application in clinics. Dr. Gupta has authored some 130 publications, including book chapters, research articles and reviews, and has spoken at several occasions in cancer prevention symposium, seminars and meetings. He has been serving in various study sections at National Cancer Institute (NCI) and Department of Defense (DOD) and reviewer for several prestigious scientific journals. His innovative research on basic and translational aspects has been featured on NBC‐5 news and highlighted in the Plain Dealer, and American Association for Cancer Research press release.

Molecular mechanism(s) of prostate and bladder carcinogenesis, role of inflammation in promoting prostate and bladder cancer, biomarker(s) for detection and prognosis of prostate cancer, Identification and characterization of prostate cancer stem cells, epigenetic mechanisms of gene silencing in prostate/bladder cancer and its reactivation by natural agents, molecular targets for prevention and treatment of prostate cancer, prostate cancer stem cells their characteristics, chemoprevention of prostate/bladder cancer by naturally occurring and/or synthetic compounds, prevention based clinical trials with promising agents